5.02 USD
↘ 0.05 (0.99%)AT CLOSE (11:59 AM EDT)
Unicycive Therapeutics, Inc. Common Stock
UNCYNASDAQ • USD
4.99
↘ 0.03 (0.60%)
POST MARKET (AS OF 07:35 PM EDT)
Post Market
AS OF 07:35 PM EDT
4.99
↘ 0.03 (0.60%)
Market: CLOSED
UNCY is currently priced at $5.01. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. UNCY is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Aug 10, 2026.
Open?$5.03
High?$5.11
Low?$4.92
Prev. Close?$5.07
Volume?727.4K
Avg. Volume?1.9M
VWAP?$5.02
Rel. Volume?0.38x
Bid / Ask
Bid?$4.96 × 500
Ask?$5.00 × 1.2K
Spread?$0.04
Midpoint?$4.98
Valuation & Ratios
Market Cap?137.5M
Shares Out?27.4M
Float?26.1M
Float %?97.8%
P/E Ratio?N/A
P/B Ratio?3.65
EPS?-$1.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
Employees
22
Market Cap
138.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-07-13
Address
1975 W. EL CAMINO REAL, SUITE 204
MOUNTAIN VIEW, CA 94040
Phone: 650-384-0642
MOUNTAIN VIEW, CA 94040
Phone: 650-384-0642
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?50
Short Sent.?52
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.78Distress
Confidence?50%Low
Short InterestHigh
Short % of Float?18.93%High
Short Interest?4.9M
Days to Cover?2.6
Free Float26.1M
Avg Daily Volume1.9M
Settlement Date2026-07-15
Financial Health
Current Ratio?2.40Strong
Quick Ratio?2.40Strong
Cash Ratio?1.41Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.65FAIR▾
Peers100
S&P48
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-106.0%WEAK▾
S&P3
ROA?-62.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28671000
Enterprise Value?$100.1M
Fundamentals ratios updated end of day